SCHEMBL8324759

SCHEMBL8324759

COc1ccc(N2CCN(C(=O)C3CC3)CC2)cc1

nearest known ligand 0.70

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 4/20 0.70
▸ ALDH1A1 P00352 4/20 0.70
▸ GAA P10253 2/20 0.70
▸ HTT P42858 1/20 0.70
▸ TDP1 Q9NUW8 1/20 0.68
▸ MAPT P10636 5/20 0.67
▸ MAPK1 P28482 1/20 0.67
▸ L3MBTL1 Q9Y468 2/20 0.66
▸ CA12 O43570 1/20 0.64
▸ CA1 P00915 1/20 0.64
▸ CA2 P00918 1/20 0.64
▸ CA9 Q16790 1/20 0.64
▸ PKM P14618 1/20 0.63
▸ AKR1C3 P42330 1/20 0.61
▸ POLB P06746 1/20 0.60
▸ GFER P55789 1/20 0.60
▸ MEN1 O00255 1/20 0.59
▸ KMT2A Q03164 1/20 0.59
▸ MTNR1B P49286 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19187554 0.83 TDP1 (0.73) SMN1; SMN2ALDH1A1TDP1MAPTMAPK1
SCHEMBL27976453 0.82 AKR1C3 (0.85) SMN1; SMN2ALDH1A1GAAHTTTDP1
SCHEMBL4182066 0.81 L3MBTL1 (0.73) SMN1; SMN2ALDH1A1GAAHTTMAPT
SCHEMBL632352 0.81 L3MBTL1 (0.73) SMN1; SMN2ALDH1A1GAAHTTMAPT
SCHEMBL12182367 0.80 L3MBTL1 (0.68) ALDH1A1GAAMAPTMAPK1L3MBTL1
SCHEMBL8365003 0.80 L3MBTL1 (0.71) SMN1; SMN2ALDH1A1GAAHTTTDP1
SCHEMBL19049426 0.80 L3MBTL1 (0.71) SMN1; SMN2ALDH1A1GAAHTTTDP1
SCHEMBL1663638 0.80 TDP1 (0.73) SMN1; SMN2ALDH1A1GAAHTTTDP1
SCHEMBL1423369 0.80 L3MBTL1 (0.71) SMN1; SMN2ALDH1A1GAAHTTTDP1
SCHEMBL28083193 0.80 L3MBTL1 (0.71) SMN1; SMN2ALDH1A1GAAHTTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004069256-A1 2-CYANOPYRROLOPYRIMIDINES AND PHARMACEUTICAL USES THEREOF NOVARTIS AG (CH) 2004-08-19 — — WO disclosed
Send feedback